IDEX (NYSE:IEX) Announces Quarterly Earnings Results, Beats Expectations By $0.21 EPS

IDEX (NYSE:IEX) announced its quarterly earnings data on Wednesday. The industrial products company reported $2.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.11 by $0.21, FiscalAI reports. IDEX had a return on equity of 15.29% and a net margin of 14.38%.The firm had revenue of $920.60 million for the quarter, compared to analysts’ expectations of $905.38 million. During the same quarter in the prior year, the firm posted $2.07 earnings per share. IDEX’s revenue for the quarter was up 6.4% compared to the same quarter last year. IDEX updated its FY 2026 guidance to 8.700-8.850 EPS and its Q3 2026 guidance to 2.200-2.250 EPS.

Here are the key takeaways from IDEX’s conference call:

• Strong second-quarter performance: Organic sales grew 5%, adjusted EBITDA margin expanded 70 basis points to 28.1%, and adjusted EPS increased 12% to $2.32, excluding a $0.08 per-share benefit from IEEPA tariff refunds.
• Orders and backlog accelerated: Organic orders increased 28%, led by 47% growth in Health & Science Technologies (HST), with particular strength in data centers, semiconductors, and space and defense. Management said longer-dated orders are improving visibility into 2027 and beyond.
• IDEX raised its 2026 outlook, now expecting 5%-6% organic growth, adjusted EBITDA margins of 27%-27.3%, and adjusted EPS of $8.70-$8.85, versus prior EPS guidance of $8.35-$8.55.
• Performance was uneven across segments: HST revenue grew 12%, while Fluid & Metering Technologies (FMT) grew 1% and Fire & Safety/ ??? Defense Products (FSDP) declined 1%; however, management cited early improvement in traditional short-cycle industrial demand and continued strength in water, mining, aerospace, and fire and safety.
• The company plans to increase 2026 capital expenditures to approximately $110 million, primarily to expand HST capacity for 2027-2028 demand, while maintaining roughly $75 million in quarterly share repurchases and retaining flexibility for bolt-on acquisitions.

IDEX Price Performance

IEX stock traded up $8.02 during trading hours on Wednesday, hitting $232.67. 871,869 shares of the stock traded hands, compared to its average volume of 770,094. The stock has a 50-day simple moving average of $219.84 and a 200 day simple moving average of $207.73. IDEX has a one year low of $157.25 and a one year high of $243.80. The company has a market cap of $17.22 billion, a P/E ratio of 34.50, a P/E/G ratio of 2.20 and a beta of 0.98. The company has a current ratio of 3.39, a quick ratio of 2.40 and a debt-to-equity ratio of 0.46.

IDEX Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, July 24th. Stockholders of record on Monday, July 6th were issued a $0.73 dividend. The ex-dividend date was Monday, July 6th. This represents a $2.92 annualized dividend and a dividend yield of 1.3%. IDEX’s dividend payout ratio is 43.20%.

Insider Transactions at IDEX

In other IDEX news, CEO Eric D. Ashleman sold 15,385 shares of the business’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $215.22, for a total value of $3,311,159.70. Following the sale, the chief executive officer directly owned 66,658 shares in the company, valued at approximately $14,346,134.76. The trade was a 18.75% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.50% of the stock is currently owned by insiders.

Hedge Funds Weigh In On IDEX

Hedge funds have recently made changes to their positions in the business. Empowered Funds LLC raised its holdings in shares of IDEX by 3.4% in the 1st quarter. Empowered Funds LLC now owns 1,646 shares of the industrial products company’s stock worth $298,000 after purchasing an additional 54 shares in the last quarter. Mackenzie Financial Corp grew its position in IDEX by 2.8% in the fourth quarter. Mackenzie Financial Corp now owns 2,562 shares of the industrial products company’s stock worth $458,000 after buying an additional 70 shares during the last quarter. Parallel Advisors LLC increased its holdings in shares of IDEX by 18.6% in the third quarter. Parallel Advisors LLC now owns 664 shares of the industrial products company’s stock valued at $108,000 after buying an additional 104 shares in the last quarter. Benjamin Edwards Inc. increased its holdings in shares of IDEX by 9.6% in the second quarter. Benjamin Edwards Inc. now owns 1,403 shares of the industrial products company’s stock valued at $246,000 after buying an additional 123 shares in the last quarter. Finally, Commerce Bank lifted its position in shares of IDEX by 5.1% during the 4th quarter. Commerce Bank now owns 2,611 shares of the industrial products company’s stock valued at $465,000 after acquiring an additional 126 shares during the last quarter. Institutional investors and hedge funds own 97.96% of the company’s stock.

Key Stories Impacting IDEX

Here are the key news stories impacting IDEX this week:

• Positive Sentiment: Quarterly results exceeded expectations. IDEX reported adjusted earnings of $2.32 per share, above the $2.11 consensus estimate and up from $2.07 a year earlier. Revenue reached $920.6 million, topping the $905.4 million estimate and increasing 6.4% year over year. IDEX quarterly earnings report
• Positive Sentiment: Demand indicators were particularly strong. Orders rose 29% on a reported basis, or 28% organically, to a record $1.07 billion. The company also reported $143.4 million in net income, compared with $131.6 million in the prior-year quarter, while diluted EPS increased 11% to $1.93. IDEX Q2 sales rise to record $921 million
• Positive Sentiment: Management raised its outlook. Full-year 2026 adjusted EPS guidance was set at $8.70–$8.85, above the $8.49 analyst consensus, while third-quarter guidance of $2.20–$2.25 also exceeded the $2.19 estimate. Full-year organic sales growth is projected at 5%–6%.
• Positive Sentiment: IDEX returned capital to shareholders through $77 million of share repurchases and $54 million in dividends, supporting the investment case.
• Neutral Sentiment: Analysts maintained an overall “Moderate Buy” consensus, while institutional ownership changes were mixed, with several large funds adding shares and others reducing or exiting positions. IDEX analyst recommendation
• Negative Sentiment: Insider activity was a modest caution: CEO Eric Ashleman sold 15,385 shares during the past six months and reported no purchases. The stock also trades at a relatively elevated valuation of roughly 34 times earnings, which could increase sensitivity to any slowdown.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on IEX shares. Weiss Ratings upgraded IDEX from a “hold (c)” rating to a “hold (c+)” rating in a report on Wednesday, June 24th. Oppenheimer raised their price objective on IDEX from $250.00 to $260.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 21st. Robert W. Baird set a $257.00 price target on shares of IDEX in a research report on Thursday, April 30th. TD Cowen raised their target price on shares of IDEX from $250.00 to $260.00 and gave the company a “buy” rating in a research note on Thursday, April 30th. Finally, Citigroup boosted their price target on shares of IDEX from $243.00 to $252.00 and gave the stock a “buy” rating in a research report on Thursday, April 30th. Six investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, IDEX has a consensus rating of “Moderate Buy” and an average target price of $244.00.

About IDEX

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.